FNY Investment Advisers LLC bought a new stake in The Allstate Corporation (NYSE:ALL - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,333 shares of the insurance provider's stock, valued at approximately $268,000.
Several other institutional investors have also recently added to or reduced their stakes in ALL. Price T Rowe Associates Inc. MD increased its stake in Allstate by 25.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider's stock valued at $2,424,710,000 after purchasing an additional 2,374,684 shares during the last quarter. Boston Partners increased its stake in Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider's stock valued at $512,627,000 after purchasing an additional 2,134,893 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Allstate by 27.2% in the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider's stock valued at $482,073,000 after purchasing an additional 497,982 shares during the last quarter. Strs Ohio acquired a new position in Allstate in the first quarter valued at $84,408,000. Finally, AQR Capital Management LLC increased its stake in Allstate by 20.3% in the first quarter. AQR Capital Management LLC now owns 2,018,403 shares of the insurance provider's stock valued at $417,244,000 after purchasing an additional 340,150 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Price Performance
Shares of NYSE ALL opened at $194.63 on Thursday. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $215.70. The business has a 50-day moving average of $204.82 and a 200-day moving average of $200.79. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43. The company has a market capitalization of $51.29 billion, a price-to-earnings ratio of 9.15, a PEG ratio of 0.70 and a beta of 0.38.
Allstate (NYSE:ALL - Get Free Report) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share for the quarter, topping the consensus estimate of $3.20 by $2.74. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The company had revenue of $15.05 billion during the quarter, compared to the consensus estimate of $16.59 billion. During the same quarter in the prior year, the business earned $1.61 earnings per share. The company's revenue was up 5.8% compared to the same quarter last year. On average, equities analysts anticipate that The Allstate Corporation will post 18.74 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts have issued reports on ALL shares. Cantor Fitzgerald raised Allstate to a "hold" rating in a research report on Wednesday, August 13th. Weiss Ratings reissued a "buy (b)" rating on shares of Allstate in a research report on Wednesday, October 8th. JPMorgan Chase & Co. boosted their price target on Allstate from $235.00 to $254.00 and gave the company an "overweight" rating in a research report on Thursday, October 9th. Raymond James Financial reissued a "strong-buy" rating and set a $260.00 price target (up previously from $250.00) on shares of Allstate in a research report on Monday, August 4th. Finally, Jefferies Financial Group boosted their price target on Allstate from $254.00 to $255.00 and gave the company a "buy" rating in a research report on Monday, August 11th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $234.60.
View Our Latest Report on ALL
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.